NHI: Company disclosure

Item 7.01. Regulation FD Disclosure The Company is furnishing its Supplemental Information for the quarter ended September 30, 2026, which is also contained on its website (www.nhireit.com). Reference Exhibit 99.1 to this Current Report on Form 8-K. The information included in this Current Report on Form 8-K (including Exhibit 99.1 hereto) shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits Exhibit Number Description 99.1 Supplemental Information for the quarter ended September 30, 2026, dated November 9 , 2026 SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. National Health Investors, Inc. Date: November 9, 2026 /s/ Todd M. Siefert Name: Todd M. Siefert Title: Chief Financial Officer